Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
4568 On Other Exchanges
Symbol
Exchange
4568 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mary Jane Helenek

Chief Executive Officer of Luitpold Pharmaceuticals Inc and President of Luitpold Pharmaceuticals Inc, Daiichi Sankyo Company, Limited
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 4 different industries.

----

Background*

Ms. Mary Jane Helenek serves as the Chief Executive Officer and President at Luitpold Pharmaceuticals Inc., a subsidiary of Daiichi Sankyo Company Limited and PharmaForce, Inc.

Corporate Headquarters*

3-5-1, Nihonbashi-honcho
Tokyo, -- 103-8426

Japan

Phone: 81 3 6225 1111
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4568:JP ¥1,861.50 JPY 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$548.8K
Jon P. Stonehouse Chief Executive Officer, President and Executive Director
BioCryst Pharmaceuticals, Inc.
$475.7K
Marc M.P. de Garidel Chairman, Chief Executive Officer and Member of Strategic Committee
Ipsen S.A.
€1.4M
Alexandre Merieux Chief Executive Officer, Director and Member of Strategy Committee
bioMérieux SA
€544.9K
Adelene Q. Perkins Chairman of The Board, Chief Executive Officer and President
Infinity Pharmaceuticals, Inc.
$552.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAIICHI SANKYO CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.